Skip to main content

LON:COS - Collagen Solutions plc (COS.L) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Collagen Solutions plc (COS.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 0
This price target is based on 0 analysts offering 12 month price targets for Collagen Solutions plc (COS.L) in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.

N/A

The current consensus among 0 investment analysts is to n/a stock in Collagen Solutions plc (COS.L). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/2/2018Cenkos SecuritiesReiterated RatingBuy
i
7/11/2017Cenkos SecuritiesReiterated RatingBuy
i
12/20/2016Beaufort SecuritiesDowngradeSpeculative Buy
i
10/13/2016Panmure GordonReiterated RatingBuy
i
9/15/2016Panmure GordonReiterated RatingBuyGBX 10
i
7/12/2016Beaufort SecuritiesReiterated RatingBuy
i
7/11/2016Panmure GordonReiterated RatingBuyGBX 10
i
(Data available from 5/16/2016 forward)
Collagen Solutions plc (COS.L) logo
Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 6.62
6.63
6.63

52 Week Range

Now: N/A

Volume

15,000 shs

Average Volume

298,181 shs

Market Capitalization

£28.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Collagen Solutions plc (COS.L)?

The following Wall Street research analysts have issued research reports on Collagen Solutions plc (COS.L) in the last year:
View the latest analyst ratings for COS.

What is the current price target for Collagen Solutions plc (COS.L)?

0 Wall Street analysts have set twelve-month price targets for Collagen Solutions plc (COS.L) in the last year. has the lowest price target set, forecasting a price of £100,000 for Collagen Solutions plc (COS.L) in the next year.
View the latest price targets for COS.

What is the current consensus analyst rating for Collagen Solutions plc (COS.L)?

Collagen Solutions plc (COS.L) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for COS.

What other companies compete with Collagen Solutions plc (COS.L)?

How do I contact Collagen Solutions plc (COS.L)'s investor relations team?

Collagen Solutions plc (COS.L)'s physical mailing address is Nova Business Park, 3 Robroyston Oval, GLASGOW, G33 1AP, United Kingdom. The company's listed phone number is +44-141-6489100. The official website for Collagen Solutions plc (COS.L) is www.collagensolutions.com.